RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
-13.46%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$627M
AUM Growth
+$627M
(-11%)
Cap. Flow
+$21.3M
Cap. Flow
% of AUM
3.4%
Top 10 Holdings %
Top 10 Hldgs %
25.67%
Holding
102
New
6
Increased
38
Reduced
34
Closed
9
Top Buys
| 1 |
Humana
HUM
|
$14.3M |
| 2 |
Cigna
CI
|
$14.3M |
| 3 |
Pfizer
PFE
|
$13.2M |
| 4 |
McKesson
MCK
|
$9.62M |
| 5 |
AET
Aetna Inc
AET
|
$9.52M |
Top Sells
| 1 |
Biogen
BIIB
|
$20.3M |
| 2 |
Johnson & Johnson
JNJ
|
$18.6M |
| 3 |
UnitedHealth
UNH
|
$9.74M |
| 4 |
CVS Health
CVS
|
$8.39M |
| 5 |
Merck
MRK
|
$7.9M |
Sector Composition
| 1 | Healthcare | 91.99% |
| 2 | Financials | 2.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Bausch Health
BHC
$2.72B
| – | – |
-32,248
| Closed | -$7.16M |
|
|
102
Biogen
BIIB
$20.8B
| – | – |
-50,291
| Closed | -$20.3M |
|